You just read:

Adastra Pharmaceuticals Announces Positive Interim Data from Phase 1b Clinical Trial of Zotiraciclib in the Treatment of Recurrent Malignant Gliomas

News provided by

Adastra Pharmaceuticals, Inc.

Jun 03, 2019, 08:10 ET